Vaillancourt, M <br/><br/>
The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance.  [electronic resource] 

 -  AIDS research and human retroviruses  Mar 1999 
 - 355-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0889-2229 
<br/><br/><label>Standard No.: </label>10.1089/088922299311321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--pharmacology<br/>Cell Line<br/>Drug Resistance, Microbial--genetics<br/>HIV Protease--drug effects<br/>HIV Protease Inhibitors--pharmacology<br/>Humans<br/>Mutation<br/>Reproducibility of Results<br/>Saquinavir--pharmacology